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Abstract
In cardiac arrest, high quality cardiopulmonary resuscitation (CPR) is a key determinant of patient survival. However,
delivery of effective chest compressions is often inconsistent, subject to fatigue and practically challenging.
Mechanical CPR devices provide an automated way to deliver high-quality CPR. However, large randomised
controlled trials of the routine use of mechanical devices in the out-of-hospital setting have found no evidence
of improved patient outcome in patients treated with mechanical CPR, compared with manual CPR. The limited data
on use during in-hospital cardiac arrest provides preliminary data supporting use of mechanical devices, but this needs
to be robustly tested in randomised controlled trials.
In situations where high-quality manual chest compressions cannot be safely delivered, the use of a mechanical device
may be a reasonable clinical approach. Examples of such situations include ambulance transportation, primary
percutaneous coronary intervention, as a bridge to extracorporeal CPR and to facilitate uncontrolled organ
donation after circulatory death.
The precise time point during a cardiac arrest at which to deploy a mechanical device is uncertain, particularly in patients
presenting in a shockable rhythm. The deployment process requires interruptions in chest compression, which may be
harmful if the pause is prolonged. It is recommended that use of mechanical devices should occur only in systems where
quality assurance mechanisms are in place to monitor and manage pauses associated with deployment.
In summary, mechanical CPR devices may provide a useful adjunct to standard treatment in specific situations,
but current evidence does not support their routine use.
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Background
High-quality chest compressions are a critical component
in the cardiac arrest chain of survival [1]. Despite its im-
portance, the sustained delivery of high-quality cardiopul-
monary resuscitation (CPR) is infrequently achieved in
clinical practice [2, 3].
Mechanical chest compression devices deliver high-quality
external chest compressions, in place of a human res-
cuer. A number of devices are currently marketed, but
devices can be broadly categorised as load distributing
band or piston devices, based on the mechanism that is
used to deliver compressions. The Autopulse (Zoll
Medical, Chelmsford, MA, USA) is a load distributing
band device, which consists of a large backplate that is
positioned behind the patient and a band that encircles
the patient’s chest to deliver compressions at a rate of 80
per minute and a depth of 20% of the anterior-posterior
chest height. The LUCAS (Physio-Control Inc./Jolife AB,
Lund, Sweden) is an example of a piston device, which
also incorporates a mechanism for active chest recoil. It
consists of two parts (a backplate and the piston mechan-
ism), which link together to encircle the patient. The de-
vice consistently delivers compressions at a rate of 102 per
minute and a depth of 5.3 cm in patients with a sternal
height greater than 18.5 cm. The key theoretical benefit to
the use of such devices is their ability to consistently
deliver high-quality chest compressions, which has been
associated with improved intra-arrest haemodynamic pro-
files [4, 5].
The purpose of this review is to provide an update on
mechanical device use for both out-of-hospital cardiac
arrest (OHCA) and in-hospital cardiac arrest (IHCA), an
overview on device use in special circumstances, and
guidance on deployment in the clinical setting.
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The importance of high quality CPR
International guidelines highlight the importance of
high-quality chest compressions, which are defined as
compressions at a depth of 5–6 cm and a rate of 100–
120 per minute, allowing full chest recoil between com-
pressions, and minimisation of interruptions [6, 7].
Despite consistent observational data showing the asso-
ciation between CPR quality and patient outcome [8, 9],
the delivery of high-quality manual chest compressions is
challenging in both the out-of-hospital and in-hospital
settings [2, 3]. Specific barriers include provider fatigue
[10, 11], physical effort to overcome stiffness of the pa-
tient’s thoracic cage [12], and compressible underlying
surfaces, such as mattresses, which can lead to shallow
chest compressions [13, 14]. For example, in an analysis of
9136 OHCA patients, only 45% received the recom-
mended guideline chest compression depth [15].
In contrast to manual chest compressions, mechanical
devices are not subject to the physical limitations of the
rescuer and are able to consistently deliver high-quality
chest compressions.
Current treatment recommendations
In 2015, the International Liaison Committee on Resus-
citation’s (ILCOR) consensus on science and treatment
recommendation process evaluated the use of mechan-
ical chest compression devices in clinical practice [16].
The evidence evaluation process made a single treatment
recommendation to cover all settings and all mechanical
device types.
Based on the expert review of the available data,
ILCOR made a weak recommendation (moderate quality
evidence) against the routine use of mechanical devices
in clinical practice. However, the review acknowledged
situations where the delivery of high quality manual
chest compressions may be impractical or dangerous to
rescuers. In such circumstances, ILCOR made a weak
recommendation based on low-quality evidence support-
ing the use of mechanical devices. The commentary ac-
companying the treatment recommendation highlighted
concerns that the deployment of mechanical devices
without appropriate training might cause patient harm
through an increase in no-flow time during the early
part of the cardiac arrest and delay defibrillation in pa-
tients with a shockable rhythm.
Out-of-hospital cardiac arrest
Routine deployment in OHCA
The routine deployment of mechanical devices has been
robustly tested in the pre-hospital setting in large
high-quality randomised controlled trials. In 2014–2015,
the CIRC (Circulation Improving Resuscitation Care) [17],
LINC (LUCAS in Cardiac Arrest) [18], and PARAMEDIC
(Prehospital Randomised Assessment of a Mechanical
Chest Compression Device in Cardiac Arrest) [19] trials
were published. These studies, alongside two earlier small
randomised studies [20, 21], are summarised in Table 1.
The CIRC trial was an industry sponsored trial, designed
to determine equivalence, superiority, or inferiority in sur-
vival to hospital discharge for OHCA patients who were
randomised in a 1:1 ratio to receive either manual CPR or
Autopulse CPR [17]. The study was terminated early, in
accordance with pre-defined stopping rules, after 4753
randomised patients were enrolled. Of those randomised,
4231 were included in the intention-to-treat analysis.
Overall, manual CPR showed a numeric increase in sur-
vival to hospital discharge compared to Autopulse CPR
(11.0 versus 9.4%). The adjusted odds ratio (OR) was 1.06
(95% confidence interval (CI) 0.83, 1.37) after adjustment
for covariates and interim analyses. This fell within the
pre-defined equivalence region (OR 0.69–1.44), although
the width of the equivalence margin incorporates the po-
tential for both significant harm and benefit [22]. Overall
hospital survival rate was higher than that reported in
similar studies (PARAMEDIC 30 day survival 6.6%; LINC
hospital survival 8.0%). This may reflect the stringent
study inclusion criteria and intensive training and over-
sight by the study team which emphasised the importance
of high-quality CPR.
The LINC trial was also an industry-sponsored efficacy
trial, in which OHCA patients were randomised in a 1:1
ratio to receive either LUCAS or manual CPR [18]. The
trial used a modified treatment algorithm for the LUCAS
arm that incorporated defibrillation without rhythm as-
sessment and 3-minute periods between rhythm assess-
ments. The study randomised 2593 patients, of which
1589 were included in the intention-to-treat analysis. In
relation to the primary outcome of 4-h survival, LUCAS
was not superior to manual chest compressions (treat-
ment difference 0.05%, 95% CI − 3.3, 3.2).
The PARAMEDIC study was an academic pragmatic
cluster randomised trial, in which ambulance vehicles
were randomised in a 2:1 ratio to receive either manual
CPR or LUCAS CPR. The treatment allocation of the in-
dividual patient was determined by the first vehicle to
arrive on scene. The study included 4471 patients, of
which 4470 were included in the primary analysis. In re-
lation to the primary outcome of 30-day survival, LU-
CAS was not superior to manual compressions (adjusted
OR 0.86, 95% CI 0.64, 1.15). The study experienced a
high incidence of non-compliance in the LUCAS CPR
arm, such that only 60% received mechanical CPR. A
CACE (compiler average causal effect) analysis, which
accounts for non-compliance, generated similar findings
to the main analysis [23].
The PARAMEDIC study also collected cost-effectiveness
and quality of life data following hospital discharge [24–26].
The long-term (up to 12 months) outcome analysis found
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no clinically important differences between groups in rela-
tion to outcomes such as survival, neurological outcome,
and quality of life at 3 months and 12 months, although the
analysis was subject to a high risk of attrition bias [24]. The
cost-effectiveness analysis found that routine use of mech-
anical CPR devices in the out-of-hospital setting was not
cost-effective [25].
A systematic review and meta-analysis by Gates et al.
[22] incorporated all five randomised controlled trials, as
summarised in Table 1, with a total patient population
of 12,206. The random-effects meta-analysis found that
mechanical CPR was not superior to manual CPR, in re-
lation to key outcomes such as return of spontaneous
circulation (OR 0.96, 95% CI 0.85, 1.10), survival at hos-
pital discharge/30 days (OR 0.89, 95% CI 0.77, 1.02), or
good neurological outcome (OR 0.76, 95% CI 0.53, 1.11).
In summary, these data do not support the routine use
of mechanical CPR in OHCA.
Use during transfer to hospital
The Universal Termination of Resuscitation rule guides
clinical teams when to consider transport from scene of
the cardiac arrest to hospital with on-going CPR [27].
Other indications for transport include situations where
potentially lifesaving treatments cannot be delivered out-
side a hospital, such as extra-corporeal CPR, re-warming
after hypothermic cardiac arrest, and invasive proce-
dures (e.g. primary percutaneous coronary intervention
(pPCI)) [28]. The process of intra-arrest transport typic-
ally requires two phases: extrication of the patient to the
ambulance and vehicular transfer to the hospital. In each
of these phases, a key challenge for the EMS crew is the
safe ongoing delivery of high-quality CPR.
The majority of OHCAs occur in the patient’s home
[29]. As such, a key challenge in the extrication stage is
manoeuvring past obstacles and downstairs whilst con-
tinuing to deliver CPR. In an observational study, re-
searchers analysed the pauses associated with this
process prior to and following the introduction of mech-
anical CPR to facilitate the extrication process [30]. In
the first period where manual CPR was provided, the
median chest compression pause during extrication was
270 s (interquartile range (IQR) 201, 387), with some
pauses recorded as being in excess of 10 min. In
Table 1 Summary of randomized controlled trials comparing routine use of mechanical CPR with manual CPR in OHCA
Load-distributing band trials Piston-device trials
Hallstrom et al. [20]a CIRC [17] Smekal et al. [21] LINC [18] PARAMEDIC [19]
Design Efficacy superiortity
multicentre RCT
Efficacy equivalence
multicentre RCT
Pilot multicentre RCT Efficacy superiority
multicentre RCT
Effectiveness superiority
multicentre RCT
Randomisation Cluster- EMS station(s)
(ratio 1:1)
Patient (ratio 1:1) Patient (ratio 1:1) Patient (ratio 1:1) Cluster- ambulance (ratio 2
manual:1 mechanical)
Inclusion criteria Adult non-traumatic
OHCA
Adult OHCA of cardiac
aetiology. EMS arrival
time≤ 16 min
Adult non-traumatic
OHCA
Adult unexpected
non-traumatic OHCA
where resuscitation
was appropriate
Adult non-traumatic
OHCA where a trial
vehicle was first
ambulance on scene
Number of cases
analysed
1071 (1071
randomised)
4231 (4753 randomised) 149 2589 (2593 randomised) 4470 (4471 randomised)
Setting US/Canada US /Europe Sweden Europe UK
Sponsor Industry Industry Academicb Industry Academic
Device used Autopulse Autopulse LUCAS LUCAS LUCAS
Primary outcome 4-h survival:
Manual 29.5% vs
mechanical 28.5%,
p = 0.74
STD
Manual 11.0% vs
mechanical 9.4%, adj.
OR 1.06 (95% CI 0.83,
1.37)c
Not specified 4-h survival
Manual 23.7% vs
mechanical 23.6%,
treatment difference
− 0.05 (95% CI − 3.3, 3.2)
30-day survival
Manual 7% vs mechanical
6%, adj. OR 0.86 (95% CI
0.64, 1.15)
Key secondary
outcomes
Cardiac aetiology
group (n = 767):
STD: Manual 9.9%
vs mechanical 5.8%,
p = 0.06 (adjusted)
Good neurological
outcome: Manual
7.5% vs mechanical
3.1%, p = 0.006
Sustained ROSC: Manual
32.3% vs mechanical
28.6%, adj. OR 0.84
(95% CI 0.73, 0.96)
Good neurological
outcome in survivors:
Manual 48.1% vs
mechanical 44.4%,
adj. OR 0.80 (95%
CI 0.47, 1.37)
ROSC: Manual 32%
vs mechanical 41%,
p = 0.30
STD: Manual 10%
vs mechanical 8%,
p = 0.78
STD: Manual 9.2% vs
mechanical 9.0%,
treatment difference
− 0.15 (95% CI − 2.4, 2.1)
Good neurological
outcome: Manual 7.3%
vs mechanical 8.1%,
treatment difference
0.78 (95% CI − 1.3, 2.8)
ROSC: Manual 31% vs
mechanical 32%, adj. OR
0.99 (95% CI 0.86, 1.14)
Good neurological outcome:
Manual 6% vs mechanical
5%, adj. OR 0.72 (95% CI 0.52,
0.99)
aTrial stopped early by data monitoring board
bOne author received consulting fee from device manufacturer
cPrimary outcome result within pre-specified boundary of equivalence. Trial stopped early in accordance with pre-specified stopping rule
EMS Emerency Medical Service, OHCA out-of-hospital cardiac arrest, RCT randomised controlled trial, STD survival to discharge, adj OR adjusted odds ratio
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contrast, after introduction of mechanical CPR, chest
compressions were delivered continuously during extri-
cation, except for the pause required to deploy the
mechanical device (median 39 s (IQR 29, 47).
For the vehicular transfer to hospital stage, there are
three main concerns. Firstly, delivery of manual CPR in
a moving vehicle is inherently unsafe, and exposes both
the patient and EMS provider to risk of injury or death
[31, 32]. Secondly, there is a risk of suboptimal CPR deliv-
ery due to acceleration forces during ambulance transport
[33]. However, evidence from clinical studies has been
mixed with some reporting a similar quality of manual
chest compressions prior to and during transfer, whilst
other studies have reported either a transfer related deteri-
oration or increased variability in quality [30, 34–36]. Fi-
nally space consideration, such as in the context of
transport by helicopter, may render delivery of manual
CPR difficult or impossible. In this setting, mechanical
chest compression devices have been used to effectively
deliver ongoing CPR during transport [37].
Based on these data, in particular the safety concerns
associated with the delivery of manual CPR during
transport, it would seem reasonable to consider the use
of mechanical CPR during transport to hospital.
Use in the emergency department
The emergency department (ED) cardiac arrest popula-
tion comprises both OHCA patients that did have a
pre-hospital ROSC and patients that arrest in the emer-
gency department. In view of limited personnel and a
case-mix that likely includes prolonged cardiac arrests,
mechanical device use in the ED may appear an attract-
ive solution. A recent multi-centre Japanese observa-
tional study analysed the outcome of 6537 cardiac arrest
patients (5619 manual CPR, 918 mechanical CPR)
treated in the ED [38]. The use of a device was associ-
ated with reduced likelihood of ROSC (unadjusted OR
0.90, 95% CI 0.77, 1.06; adjusted 0.71, 95% CI 0.53, 0.94)
and hospital survival (unadjusted OR 0.97, 95% CI 0.62,
1.51; adjusted 0.40, 95% CI 0.20, 0.78). However, the de-
cision as to whether or not to use a mechanical device
was made on a patient by patient basis, such that there
is a high risk that selective enrolment introduced un-
measured confounding variables which may have biased
the results.
In a before–after study in two Singaporean hospitals,
researchers compared patient outcomes prior to and fol-
lowing the implementation of the Autopulse device as
part of the treatment for ED cardiac arrests [39]. In total,
1011 (459 manual CPR period; 552 mechanical CPR
period) patients were studied. Unadjusted ORs show an
association between treatment in the mechanical CPR
period and improved ROSC (OR 1.89, 95% CI 1.43,
2.50), hospital survival (OR 2.55, 95% CI 1.00, 6.47), and
good neurological outcome (OR 8.7, 95% CI 1.1, 71.6), but
the interpretation of these findings is complicated by
marked differences in baseline patient characteristics (e.g.
initial rhythm, arrest location). Adjusted analyses showed
an association between treatment in the mechanical CPR
period and ROSC (OR 1.60, 95% 1.16, 2.22), but no associ-
ation was observed in relation to any other outcome.
The reason for the apparent contrast in findings may
reflect differences in patient population, study risk of
bias (selection bias, effect of unmeasured confounders),
or the strategy used to deploy the mechanical device. In
particular, the team that deployed the device in Ong
et al.’s study [40] had received focussed team training to
optimise device deployment, thereby minimising pauses
associated with its use. Overall, the findings of these
studies with their inherent risk of bias do not support
the routine use of mechanical CPR in the ED.
In-hospital cardiac arrest
In contrast to the OHCA setting, few studies have
sought to evaluate the routine use of mechanical CPR in
the IHCA setting. A recent systematic review and
meta-analysis identified only three randomised con-
trolled trials which enrolled 234 patients [41].
The largest of these trials, and the only study pub-
lished in the last 20 years, enrolled 150 in-hospital car-
diac arrest patients who were randomised to receive
either mechanical CPR delivered by a piston device or
manual CPR [42]. The study report is available only in
Chinese. After translation, unfortunately, key patient
characteristics, such as initial rhythm, are not reported.
The study reported that the use of a mechanical device
improved survival to hospital discharge (OR 2.81, 95%
CI 1.26, 6.24). This trial, alongside the two other trials
[43, 44], are summarised in Table 2.
The meta-analysis of the three randomised trials
alongside six (455 patients) observational studies found
very low quality evidence supporting an association be-
tween mechanical CPR use and increased likelihood of
ROSC (OR 2.14, 95% CI 1.11, 4.13) and survival to hos-
pital discharge/30 days (OR 2.34, 95% CI 1.42, 3.85) [41].
Neurological outcome was not assessed in any study.
The results of the meta-analysis were broadly consistent
between the sub-groups of randomised controlled trials
and observational studies.
These findings seemingly contrast with research findings
from out-of-hospital studies [22]. Reasons for this apparent
discrepancy may reflect differences in either the quality of
evidence or clinical characteristics between the two settings,
such that mechanical devices may be more effective than
manual chest compressions in the hospital setting. Exam-
ples of such characteristics include the opportunity for early
device deployment and the challenges of delivering effective
manual chest compressions on a bed mattress.
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Based on this discrepancy, the need for a randomised
controlled trial in the in-hospital setting was recently
highlighted as a research priority [45]. The ongoing
COMPRESS-RCT (ISRCTN38139840) study is assessing
the feasibility of undertaking such a trial.
Risk of injury during mechanical device use
Injuries secondary to manual chest compression are
common and well-reported [46]. Common injuries in-
clude fractures (rib, sternal), pneumothoraces, and vis-
ceral organ damage (liver, spleen, heart) [46–48]. Several
case reports have purportedly linked mechanical device
use with clinically important injuries, thereby driving
concern that mechanical devices may increase risk of in-
jury compared with manual CPR [49–51]. Whilst evi-
dence from cohort studies has produced mixed results,
interpretation of these studies is challenging as they are
prone to selection bias and the quality of manual CPR
delivered, as the comparator group, is generally not re-
corded [52–55]. The PARAMEDIC, LINC, and CIRC tri-
als were designed to examine the clinical effectiveness of
mechanical devices, rather than to specifically examine
injury, but it is noteworthy that these trials did not re-
port a difference in injury patterns or severity between
patients receiving manual and mechanical chest com-
pression [17–19].
Koster et al. recently published a non-inferiority rando-
mised controlled trial that provided the most robust evi-
dence in relation to injury attributable to mechanical chest
compression devices [56]. In total, 374 patients were ran-
domised to receive LUCAS CPR, Autopulse CPR, or to
continue to receive manual CPR [56]. The primary out-
come was serious or life-threatening resuscitation-related
visceral organ damage. Outcome data were available for
90% of participants. Compared to manual CPR, the
non-inferiority analysis showed that LUCAS did not in-
crease the risk of injury. However, an increase in injury
could not be ruled out with the Autopulse device. The
depth of manual chest compressions delivered in the man-
ual CPR arm was 48 mm (SD 9), which is slightly lower
than the current recommended target depth of 50 mm [6].
Adjunct to advanced treatments
pPCI and CT scan
Delivery of high quality manual chest compressions dur-
ing imaging procedures, such as coronary angiography
or CT scan, is practically challenging due to the required
positioning of the radiology equipment. Several case
series describe the experience of specialist centres in
performing intra-arrest coronary angiography and pPCI
facilitated by mechanical CPR, with reported hospital
survival rates of approximately 25% [57–59]. Wagner
et al. [58] acknowledge that movement during CPR in-
creases the complexity of the procedure, but recommend
strategies such as a brief CPR pause during stenting to
overcome this challenge. Whether the routine transfer of
patients in refractory cardiac arrest for pPCI during
on-going CPR improves patient outcome remains to be
determined.
Transporting a patient in cardiac arrest to the CT scan-
ner is rarely likely to improve management. However,
there may be cases where a patient scheduled for a CT
scan has a cardiac arrest just prior to the commencement
of the scan. In these circumstances, it may be reasonable
to proceed with the scan to confirm the presence of a
treatable reversible cause, such as a massive pulmonary
Table 2 Summary of randomized controlled trials comparing routine use of mechanical CPR with manual CPR in IHCA
Load-distributing band trials Piston-device trials
Halperin et al. [44] Taylor et al. [43] Lu et al. [42]a
Design Efficacy superiortity single-centre RCT Efficacy superiortity single-centre RCT Efficacy superiority single-centre RCT
Randomisation Patient (ratio 1:1) Patient (ratio 1:1) Patient (ratio 1:1)
Inclusion criteria IHCA of less than 20-min duration
following tracheal intubation and
adrenaline administration
IHCA of less than 10-min duration IHCA of less than 10-min duration
Number of cases analysed 34 50 150
Setting US US China
Sponsor Academicb Academic Unclear
Device used Load-distributing band device Thumper device Thumper device
Primary outcome ROSC
Manual 18% vs mechanical 47%,
OR 4.15 (95% CI 0.86, 19.92)
One-hour survival
Manual 38% vs mechanical 42%,
OR 1.14 (95% CI 0.37, 3.55)
STD
Manual 15% vs mechanical 33%,
OR 2.81 (95% CI 1.26, 6.24)
Key secondary outcomes 24-h survival: Manual 6% vs
mechanical 18%
STD: Manual 8% vs mechanical
13%, OR 1.71 (95% CI 0.26, 11.26)
ROSC: Manual 38% vs mechanical
55%, OR 2.03 (95% CI 1.06, 3.90)
aPublished only in Chinese
bNine authors report equity interest in company holding device patent
IHCA in-hospital cardiac arrest, RCT randomised controlled trial, STD survival to discharge
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embolism. In such patients, imaging of acceptable quality
can be obtained whilst CPR is delivered by a mechanical
device [60].
Extracorporeal CPR
Extracorporeal CPR (E-CPR) is a cardiac arrest treat-
ment strategy whereby patients are placed on cardiopul-
monary bypass. Whilst evidence supporting E-CPR is
limited and based on observational studies, a number of
regions have established systems where E-CPR may be
offered to patients who might narrow inclusion criteria
[61, 62]. Several of these systems use mechanical CPR to
facilitate the insertion of the E-CPR intravascular cannu-
lae [63–65].
In Paris, for example, mechanical CPR has been used
as a bridge to pre-hospital E-CPR in 156 patients, with
an overall ROSC rate of 77.8% [63]. Similarly, the Aus-
tralian CHEER study included 26 patients in refractory
cardiac arrest that were treated with a care protocol
comprising mechanical CPR, therapeutic hypothermia,
E-CPR, and pPCI [64]. Fourteen (54%) survived to hos-
pital discharge, all of whom had full neurological
recovery.
The ongoing Prague-based Hyperinvasive Approach in
Cardiac Arrest trial (NCT01511666) will provide import-
ant new information about the role of mechanical CPR
as a bridge to E-CPR [66].
Organ donation
Uncontrolled donation after circulatory death (uDCD)
provides a system whereby organs can be retrieved after
sudden cardiac arrest in cases where it has not been pos-
sible to obtain a ROSC [67]. This enables the retrieval of
organs such as lungs, kidneys, and liver. Whilst this con-
cept poses legal, ethical, and practical challenges, it pro-
vides an opportunity to increase the number of viable
donor organs [67, 68].
The use of mechanical CPR as a bridge to non-heart
beating donation has also been described in a number of
countries [37, 67]. The use of mechanical CPR provides
a system to limit warm ischaemic time [68] whilst poten-
tially providing a controlled setting in which consent for
donation can be sought. In Spain, a comparable number
of organs were transplanted with a similar graft failure
rate following implementation of mechanical CPR as
part of a uDCD protocol [69]. The study also highlighted
the challenge of delivering such a system through its re-
port that three patients, following protocol implementa-
tion and initiation of mechanical CPR, obtained ROSC,
of which one made a good recovery.
Clinical decisions to refer for advanced lifesaving inter-
ventions (e.g. E-CPR) versus organ donation present eth-
ical dilemmas that require careful consideration [70].
Optimising clinical use of mechanical devices
Timing of deployment
In systems where mechanical devices are available, a key
challenge for the clinician is the decision as to the time
point during the cardiac arrest at which to deploy the
mechanical chest compression device. In a meta-regression
of out-of-hospital data, Bonnes et al. [71] identified an as-
sociation between improved outcome and earlier device
deployment.
A sub-group analysis in the PARAMEDIC trial identi-
fied decreased 30-day survival in patients treated with a
mechanical device that presented in a shockable rhythm
(odds ratio 0.71, 95% CI 0.52, 0.98) [19]. One plausible
explanation for this is that the study protocol required
deployment of the mechanical device prior to defibrilla-
tion, leading to delays in defibrillation in the mechanical
CPR arm, although this delay was not measured in the
trial. In contrast, the LINC study, which adopted a
modified mechanical CPR treatment algorithm, found
no difference in outcome between treatment groups in
patients presenting in a shockable rhythm (e.g. hospital
discharge treatment difference 0.6%, 95% CI − 5.6, 6.9),
despite an increased median time to first shock in the
mechanical CPR arm (mechanical 4 min (IQR 2,5) vs
manual 3 min (IQR 2, 4), P < 0.001) [72].
Delivery of high-quality manual chest compressions
for a prolonged period of time is physically exhausting
[11, 73]. In the context of a prolonged cardiac arrest
with limited personnel available, use of a mechanical
chest compression device may be a reasonable strategy
to avoid the potential harm associated with suboptimal
chest compression delivery.
Based on these data, it would seem reasonable to de-
ploy devices early in circumstances where high-quality
manual chest compressions cannot be safely delivered.
In patients where high-quality CPR is deliverable, de-
layed deployment would seem prudent in patients in a
shockable rhythm.
Deployment
The key modifiable risk associated with mechanical de-
vice use is the pause associated with device deployment.
There is a risk that prolonged pauses associated with de-
vice deployment during the early part of a cardiac arrest
event may offset the subsequent potential benefit of im-
proved CPR.
In clinical practice, published literature reports marked
variability in the hands-off time during device deploy-
ment, with pauses in excess of 1 minute being reported
[74]. In the LINC trial, the median reported chest com-
pression pause associated with device deployment was
36.0 s (IQR 19.5, 45.5) [75]. However, subsequent im-
provement in flow-fraction following device deployment
meant that the median flow-fraction over the first 10
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minutes of the cardiac arrest was higher in the mechan-
ical CPR arm (mechanical 0.84 (IQR 0.78, 0.91) vs man-
ual 0.79 (IQR 0.70, 0.86), p < 0.001). A similar pattern
was observed in the CIRC trial [17].
High-quality training that focuses on minimising
pauses is an effective strategy to reduce chest compres-
sion pauses associated with device deployment [40, 76].
Levy et al. [76] implemented a system which incorpo-
rated a choreographed team approach to device deploy-
ment, debriefing, mock resuscitation drills, and
adaptations to the deployment process to minimise
pauses. The implementation of this system was associ-
ated with a significant reduction in the median pause
immediately prior to the first mechanical chest compres-
sion (21 (IQR 15, 31) vs 7 (IQR 4, 12) s, p < 0.001).
Whenever mechanical CPR systems are deployed, a
careful system of quality assurance should be initiated to
ensure optimal device deployment and avoidance of pro-
longed interruptions in chest compressions.
Future developments
The integration of mechanical CPR with other technolo-
gies, such as active compression–decompression technol-
ogy or impedance threshold devices [77], has the potential
to impact on the efficacy of currently marketed mechan-
ical chest compression devices. However, a recent study
found that the integration of active compression–decom-
pression technology with a LUCAS mechanical chest
compression device did not improve end tidal carbon di-
oxide, compared with use of a LUCAS without the tech-
nology [78].
There may be the opportunity in the future for mech-
anical chest compression devices to titrate chest com-
pression delivery to physiological endpoints, such as
end-tidal carbon dioxide or arterial blood pressure [79].
Conclusions
The provision of high-quality CPR is a key modifiable
factor associated with survival in cardiac arrest. Mechan-
ical chest compression devices consistently deliver
high-quality chest compressions, but this does not trans-
late into improved patient outcomes when devices are
routinely used in OHCA. Further trials are needed to
evaluate the routine use of mechanical devices in IHCA.
The use of mechanical devices in specific circum-
stances (e.g. ambulance/helicopter transport, pPCI)
where high-quality chest compressions cannot be safely
delivered may be a reasonable strategy. In all situations
where mechanical devices are used, clinicians must en-
sure that the device is deployed with minimal interrup-
tion to chest compression delivery.
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